Logo image of MDP

MEREDITH CORP (MDP) Stock Fundamental Analysis

NYSE:MDP - New York Stock Exchange, Inc. - Common Stock

59.07  +0.07 (+0.12%)

After market: 59.15 +0.08 (+0.14%)

Fundamental Rating

2

MDP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 93 industry peers in the Media industry. Both the profitability and financial health of MDP have multiple concerns. MDP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MDP had positive earnings in the past year.
MDP Yearly Net Income VS EBIT VS OCF VS FCFMDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M -200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 5.25%
ROE 42.48%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDP Yearly ROA, ROE, ROICMDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 -60

1.3 Margins

Industry RankSector Rank
OM 17.53%
PM (TTM) 9.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDP Yearly Profit, Operating, Gross MarginsMDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for MDP has been increased compared to 1 year ago.
Compared to 1 year ago, MDP has an improved debt to assets ratio.
MDP Yearly Shares OutstandingMDP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
MDP Yearly Total Debt VS Total AssetsMDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

MDP has an Altman-Z score of 1.43. This is a bad value and indicates that MDP is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 4.03 is on the high side and indicates that MDP has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Altman-Z 1.43
ROIC/WACCN/A
WACCN/A
MDP Yearly LT Debt VS Equity VS FCFMDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B

2.3 Liquidity

MDP has a Current Ratio of 1.39. This is a normal value and indicates that MDP is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.36 indicates that MDP should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.36
MDP Yearly Current Assets VS Current LiabilitesMDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.19% over the past year.
Measured over the past years, MDP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.98% on average per year.
MDP shows a small growth in Revenue. In the last year, the Revenue has grown by 6.23%.
Measured over the past years, MDP shows a quite strong growth in Revenue. The Revenue has been growing by 12.54% on average per year.
EPS 1Y (TTM)63.19%
EPS 3Y13.34%
EPS 5Y11.98%
EPS Q2Q%-17.31%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y9.56%
Revenue growth 5Y12.54%
Sales Q2Q%2.18%

3.2 Future

Based on estimates for the next years, MDP will show a small growth in Earnings Per Share. The EPS will grow by 3.74% on average per year.
The Revenue is expected to grow by 1.19% on average over the next years.
EPS Next Y-20.29%
EPS Next 2Y5.73%
EPS Next 3Y-1.56%
EPS Next 5Y3.74%
Revenue Next Year0.12%
Revenue Next 2Y3.22%
Revenue Next 3Y1.15%
Revenue Next 5Y1.19%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDP Yearly Revenue VS EstimatesMDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
MDP Yearly EPS VS EstimatesMDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.49, the valuation of MDP can be described as very reasonable.
MDP is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
MDP is valuated reasonably with a Price/Forward Earnings ratio of 9.10.
MDP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 10.49
Fwd PE 9.1
MDP Price Earnings VS Forward Price EarningsMDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.89
MDP Per share dataMDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.88
EPS Next 2Y5.73%
EPS Next 3Y-1.56%

More info and screens

2

5. Dividend

5.1 Amount

MDP has a Yearly Dividend Yield of 1.01%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 1.01, MDP pays less dividend than the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 1.01%

5.2 History

MDP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
MDP Yearly Dividends per shareMDP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2Y5.73%
EPS Next 3Y-1.56%
MDP Yearly Income VS Free CF VS DividendMDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M 300M

More info and screens

MEREDITH CORP

NYSE:MDP (12/1/2021, 8:48:41 PM)

After market: 59.15 +0.08 (+0.14%)

59.07

+0.07 (+0.12%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners1.09%
Ins Owner Change0%
Market Cap2.79B
Analysts50.77
Price Target56.1 (-5.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.01%
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.49
Fwd PE 9.1
P/S 0.93
P/FCF N/A
P/OCF N/A
P/B 4.1
P/tB N/A
EV/EBITDA 7.89
EPS(TTM)5.63
EY9.53%
EPS(NY)6.49
Fwd EY10.99%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS63.4
BVpS14.42
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.88
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 42.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 17.53%
PM (TTM) 9.66%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.36
Altman-Z 1.43
F-Score9
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.19%
EPS 3Y13.34%
EPS 5Y11.98%
EPS Q2Q%-17.31%
EPS Next Y-20.29%
EPS Next 2Y5.73%
EPS Next 3Y-1.56%
EPS Next 5Y3.74%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y9.56%
Revenue growth 5Y12.54%
Sales Q2Q%2.18%
Revenue Next Year0.12%
Revenue Next 2Y3.22%
Revenue Next 3Y1.15%
Revenue Next 5Y1.19%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A